VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CTVA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CTVACorteva, Inc.
$83.37$56.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCTVABalance Sheet

Corteva, Inc. (CTVA) Balance Sheet

9Y historyFree accessUpdated daily

The company maintains a conservative financial profile with a debt-to-equity ratio of 0.14 as of 2026Q1, supported by a current ratio consistently above 1.40.

CTVA Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Total Current Assets17.39B17.34B15.1B16.26B16.8B15.55B14.77B13.52B22.97B23.05B
Cash & Short-Term Investments1.97B4.53B3.17B2.74B3.31B4.54B3.79B1.77B2.27B8.76B
Cash Only1.96B4.52B3.11B2.64B3.19B4.46B3.53B1.76B2.27B7.81B
Short-Term Investments2M9M63M98M124M86M269M5M5M952M
Accounts Receivable9.09B6.37B5.68B5.49B5.7B4.81B4.93B5.53B5.26B5.24B
Days Sales Outstanding162.81133.64122.53116.28119.21112.17126.47145.73134.38134.29
Inventory5.2B5.67B5.43B6.9B6.81B5.18B4.88B5.03B5.31B8.63B
Days Inventory Outstanding267.59210.72208.07253.84238.22205.07209.47214.19194.83375.04
Other Current Assets1.13B767M820M1.13B968M1.01B1.17B1.19B10.13B423M
Total Non-Current Assets25.33B25.51B25.73B26.74B25.82B26.8B27.88B28.88B85.71B89.91B
Property, Plant & Equipment9.62B4.22B4.1B4.29B4.25B4.33B4.4B4.55B4.54B12.44B
Fixed Asset Turnover3.22x4.12x4.12x4.02x4.10x3.62x3.23x3.05x3.14x1.15x
Goodwill10.41B10.46B10.41B10.61B9.96B10.11B10.27B10.23B10.19B45.59B
Intangible Assets8.15B8.3B8.88B9.63B9.34B10.04B10.75B11.42B12.05B0
Long-Term Investments435M160M134M115M102M76M66M66M138M1.59B
Other Non-Current Assets-3.24B2.04B1.81B1.52B1.69B1.8B1.94B2.33B58.48B29.81B
Total Assets42.72B42.84B40.83B43B42.62B42.34B42.65B42.4B108.68B112.96B
Asset Turnover0.42x0.41x0.41x0.40x0.41x0.37x0.33x0.33x0.13x0.13x
Asset Growth %7.76%4.95%-5.05%0.89%0.65%-0.72%0.59%-60.99%-3.79%-
Total Current Liabilities11.85B12.13B10.39B10.41B10.74B9.56B8.55B8.24B13.31B12.14B
Accounts Payable4.19B4.4B4.04B4.28B4.89B4.13B3.62B3.7B3.8B4.83B
Days Payables Outstanding218.69163.54154.71157.48171.2163.34155.1157.58139.35209.87
Short-Term Debt1.67B894M750M197M23M17M3M3M2.13B2.78B
Deferred Revenue (Current)7.19B3.58B3.29B3.41B3.39B3.2B2.66B2.58B2.21B2.01B
Other Current Liabilities3.22B00000232M381M3.17B2.52B
Current Ratio1.47x1.43x1.45x1.56x1.56x1.63x1.73x1.64x1.73x1.90x
Quick Ratio1.03x0.96x0.93x0.90x0.93x1.08x1.16x1.03x1.33x1.19x
Cash Conversion Cycle211.7180.82175.89212.65186.23153.9180.83202.34189.86299.45
Total Non-Current Liabilities6.26B6.33B6.41B7.31B6.33B7.16B9.04B9.6B20.22B25.89B
Long-Term Debt1.68B1.69B1.95B2.29B1.28B1.1B1.1B115M5.72B10.29B
Capital Lease Obligations00002M3M395M5M67M4M
Deferred Tax Liabilities1.17B251M478M899M1.12B1.22B893M920M05.84B
Other Non-Current Liabilities4.29B4.4B3.98B4.12B3.93B4.84B6.14B8.56B12.81B9.71B
Total Liabilities18.11B18.46B16.8B17.72B17.08B16.72B17.59B17.84B33.53B38.03B
Total Debt3.36B2.58B2.7B2.49B1.31B1.12B1.11B127M7.94B13.07B
Net Debt1.39B-1.94B-403M-155M-1.88B-3.34B-2.42B-1.64B5.67B5.26B
Debt / Equity0.14x0.11x0.11x0.10x0.05x0.04x0.04x0.01x0.11x0.17x
Debt / EBITDA0.99x0.68x0.81x0.75x0.41x0.44x0.55x0.06x3.39x28.54x
Net Debt / EBITDA0.41x-0.51x-0.12x-0.05x-0.60x-1.30x-1.20x-0.75x2.42x11.49x
Interest Coverage5.82x10.38x6.47x5.69x19.05x79.20x16.00x-1.32x-19.20x-4.05x
Total Equity24.61B24.39B24.03B25.28B25.54B25.62B25.06B24.55B75.15B74.93B
Equity Growth %6.6%1.48%-4.94%-1.03%-0.32%2.23%2.07%-67.33%0.29%-
Book Value per Share36.5336.2334.5335.5135.2534.5533.3632.76100.2899.99
Total Shareholders' Equity24.36B24.14B23.79B25.04B25.3B25.38B24.82B24.31B74.66B74.76B
Common Stock7M7M7M7M7M7M7M7M00
Retained Earnings436M-67M55M-41M250M524M0-425M0175M
Treasury Stock0000000000
Accumulated OCI-2.94B-2.8B-3.47B-2.68B-2.81B-2.9B-2.89B-3.27B74.66B-381M
Minority Interest243M242M241M242M239M239M239M246M493M172M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Seasonal Working Capital Volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Capital Base Stability Amid Seasonality

According to reported financial statements, Corteva has maintained a stable total asset base hovering near $42 billion, suggesting that the company's underlying capital structure remains resilient despite the significant quarterly fluctuations in cash and working capital inherent to its agricultural input business model.

The consistency in total assets over the last ten quarters indicates a disciplined approach to asset management despite the inherent volatility of the agricultural cycle. Investors should monitor whether this stability persists as the company integrates recent acquisitions in the biologicals space, which may shift the asset composition toward higher-value intangible assets.

Conservative Leverage Supports Financial Flexibility

Based on the provided balance sheet data, Corteva maintains a highly conservative debt-to-equity ratio that peaked at only 0.23 in 2024Q3, reflecting a strategic preference for low leverage that provides a significant buffer against the cyclical downturns common in the agricultural inputs sector.

The company's ability to manage debt levels while navigating seasonal cash flow swings suggests a robust balance sheet that is not overly reliant on external financing. This low leverage profile appears to provide management with the necessary flexibility to pursue strategic M&A or return capital to shareholders without compromising long-term solvency.

Seasonal Liquidity Buffers Remain Adequate

As reported in recent filings, the current ratio has consistently remained above 1.40, with a peak of 1.72 in 2024Q2, demonstrating that the company maintains sufficient short-term liquidity to manage the massive working capital requirements associated with the Northern Hemisphere's spring planting and harvest cycles.

The fluctuation in the current ratio is a direct reflection of the company's seasonal inventory and accounts receivable cycles rather than a sign of liquidity distress. This pattern suggests that the company is well-positioned to meet its short-term obligations even during periods of peak operational intensity.

Equity Quality Driven by Retained Earnings

Based on the provided figures, equity has remained relatively stable near $24 billion, though the volatility in retained earnings, which swung from a $1.5 billion peak in 2025Q2 to a $67 million deficit in 2025Q4, warrants further investigation into the impact of seasonal profitability on shareholder value.

The variability in retained earnings highlights the sensitivity of the company's bottom line to seasonal demand and commodity price fluctuations. While the equity base appears solid, the periodic dips in retained earnings suggest that the company's ability to grow book value is heavily dependent on the successful execution of its high-margin seed and trait strategy.

Goodwill Concentration Risks Future Impairment

As indicated by the balance sheet, goodwill remains a significant component of total assets at approximately $10.4 billion, representing nearly 25% of the total asset base, which suggests that future earnings could be sensitive to potential impairment charges if acquired business units fail to meet performance expectations.

The high concentration of goodwill warrants close monitoring, particularly as the company pivots toward new growth areas like biologicals. If the anticipated synergies from these acquisitions do not materialize, the company may face non-cash write-downs that could negatively impact the reported equity position and overall balance sheet health.

CTVA — Frequently Asked Questions

Quick answers to the most common questions about buying CTVA stock.

What are the total assets of Corteva, Inc. (CTVA)?

As of 2025, Corteva, Inc. (CTVA) had total assets of $42.84B including $17.34B in current assets.

How much debt does Corteva, Inc. (CTVA) have?

Corteva, Inc. (CTVA) carries total debt of $2.58B, offset by $4.53B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Corteva, Inc.?

Corteva, Inc. (CTVA) has total shareholders' equity (book value) of $24.14B ($36.23 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Corteva, Inc.'s current ratio and liquidity?

Corteva, Inc. (CTVA) reported a current ratio of 1.43x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.